STAT3 and cancer: In cancer, sustained STAT3 activation occurs through several mechanisms, e.g., excessive cytokine and growth factor stimulation, hyper-activation or mutation of receptor/non-receptor associated kinases (JAK and Src family kinases), or loss of negative regulators (SOCS and PIAS proteins) [7,13].